Anna Dziubina

665 total citations
31 papers, 567 citations indexed

About

Anna Dziubina is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Anna Dziubina has authored 31 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in Anna Dziubina's work include Neuroscience and Neuropharmacology Research (17 papers), Adenosine and Purinergic Signaling (12 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Anna Dziubina is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Adenosine and Purinergic Signaling (12 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Anna Dziubina collaborates with scholars based in Poland, Italy and Germany. Anna Dziubina's co-authors include Krystyna Gołembiowska, Barbara Filipek, Jacek Sapa, Katarzyna Kamińska, Tadeusz Librowski, Barbara A. Zieba, Jadwiga Wardas, Maria Śmiałowska, Krystyna Ossowska and Helena Domin and has published in prestigious journals such as PLoS ONE, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Anna Dziubina

29 papers receiving 558 citations

Peers

Anna Dziubina
Katarzyna Kamińska Poland
Pedro Garção Portugal
Silva Fredduzzi Italy
Jorge Baruch Pineda-Farías Mexico
Mary Cohen-Williams United States
Simone Molz Brazil
Marcos Emílio Frizzo Brazil
Anna Wilkaniec Poland
Vincenzo Di Matteo Italy
Junko Yarimizu Japan
Katarzyna Kamińska Poland
Anna Dziubina
Citations per year, relative to Anna Dziubina Anna Dziubina (= 1×) peers Katarzyna Kamińska

Countries citing papers authored by Anna Dziubina

Since Specialization
Citations

This map shows the geographic impact of Anna Dziubina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Dziubina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Dziubina more than expected).

Fields of papers citing papers by Anna Dziubina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Dziubina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Dziubina. The network helps show where Anna Dziubina may publish in the future.

Co-authorship network of co-authors of Anna Dziubina

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Dziubina. A scholar is included among the top collaborators of Anna Dziubina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Dziubina. Anna Dziubina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rapacz, Anna, Anna Dziubina, Elżbieta Pękala, et al.. (2023). Mechanochemical synthesis and anticonvulsant activity of 3-aminopyrrolidine-2,5-dione derivatives. Biomedicine & Pharmacotherapy. 168. 115749–115749. 2 indexed citations
3.
Dziubina, Anna, et al.. (2022). Antinociceptive and Antiallodynic Activity of Some 3-(3-Methylthiophen-2-yl)pyrrolidine-2,5-dione Derivatives in Mouse Models of Tonic and Neuropathic Pain. International Journal of Molecular Sciences. 23(7). 4057–4057. 2 indexed citations
4.
Kotańska, Magdalena, Anna Dziubina, Małgorzata Szafarz, et al.. (2022). Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice. International Journal of Molecular Sciences. 23(21). 13439–13439. 4 indexed citations
5.
Dziubina, Anna, et al.. (2022). Synthesis and antinociceptive activity of four 1H‐isoindolo‐1,3(2H)‐diones. Archiv der Pharmazie. 355(7). e2100423–e2100423. 4 indexed citations
6.
Kotańska, Magdalena, Anna Dziubina, Małgorzata Szafarz, et al.. (2020). KD-64—A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist—Caffeine does not reduce diet-induced obesity in mice. PLoS ONE. 15(6). e0229806–e0229806. 12 indexed citations
7.
Kotańska, Magdalena, Małgorzata Szafarz, Anna Dziubina, et al.. (2020). PSB 603 – a known selective adenosine A2B receptor antagonist – has anti-inflammatory activity in mice. Biomedicine & Pharmacotherapy. 135. 111164–111164. 25 indexed citations
8.
Dziubina, Anna, Małgorzata Zygmunt, Jacek Sapa, et al.. (2016). Evaluation of antidepressant-like and anxiolytic-like activity of purinedione-derivatives with affinity for adenosine A2A receptors in mice. Pharmacological Reports. 68(6). 1285–1292. 8 indexed citations
9.
Pytka, Karolina, Anna Dziubina, Katarzyna Młyniec, et al.. (2015). The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect. Pharmacological Reports. 68(2). 443–450. 53 indexed citations
10.
Sałat, Kinga, Adrian Podkowa, Katarzyna Kulig, et al.. (2014). Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression. Pharmacological Reports. 67(3). 465–472. 55 indexed citations
11.
Kuter, Katarzyna, Wacław Kolasiewicz, Urszula Głowacka, et al.. (2014). Pramipexole but not imipramine or fluoxetine reverses the “depressive-like” behaviour in a rat model of preclinical stages of Parkinson's disease. Behavioural Brain Research. 271. 343–353. 27 indexed citations
12.
Śmiałowska, Maria, Krystyna Gołembiowska, Małgorzata Kajta, et al.. (2011). Selective mGluR1 Antagonist EMQMCM Inhibits the Kainate-Induced Excitotoxicity in Primary Neuronal Cultures and in the Rat Hippocampus. Neurotoxicity Research. 21(4). 379–392. 25 indexed citations
13.
Gołembiowska, Krystyna & Anna Dziubina. (2011). Effect of Adenosine A2A Receptor Antagonists and l-DOPA on Hydroxyl Radical, Glutamate and Dopamine in the Striatum of 6-OHDA-Treated Rats. Neurotoxicity Research. 21(2). 222–230. 22 indexed citations
14.
Wydra, Karolina, Magdalena Zaniewska, Anna Dziubina, et al.. (2011). P.2.023 In vivo microdialysis studies of brain dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction. European Neuropsychopharmacology. 21. S52–S53. 1 indexed citations
15.
Domin, Helena, et al.. (2010). Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus. Pharmacological Reports. 62(6). 1051–1061. 21 indexed citations
16.
Gołembiowska, Krystyna, et al.. (2009). Effect of Adenosine A2A Receptor Antagonists on l-DOPA-Induced Hydroxyl Radical Formation in Rat Striatum. Neurotoxicity Research. 15(2). 155–166. 24 indexed citations
17.
Gołembiowska, Krystyna & Anna Dziubina. (2004). Striatal adenosine A2A receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats. Neuropharmacology. 47(3). 414–426. 42 indexed citations
18.
Gołembiowska, Krystyna & Anna Dziubina. (2003). Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on l-DOPA biotransformation in rat striatum. Brain Research. 998(2). 208–217. 15 indexed citations
19.
Gołembiowska, Krystyna & Anna Dziubina. (2001). Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex.. PubMed. 52(6). 441–8. 57 indexed citations
20.
Gołembiowska, Krystyna & Anna Dziubina. (2001). Involvement of adenosine in the effect of antidepressants on glutamate and aspartate release in the rat prefrontal cortex. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(6). 663–670. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Kamińska Breakdown of academic impact, for papers by Pedro Garção Breakdown of academic impact, for papers by Silva Fredduzzi Breakdown of academic impact, for papers by Jorge Baruch Pineda-Farías Breakdown of academic impact, for papers by Mary Cohen-Williams Breakdown of academic impact, for papers by Simone Molz Breakdown of academic impact, for papers by Marcos Emílio Frizzo Breakdown of academic impact, for papers by Anna Wilkaniec Breakdown of academic impact, for papers by Vincenzo Di Matteo Breakdown of academic impact, for papers by Junko Yarimizu
Rankless by CCL
2026